MetaADEDB 2.0 @ LMMD
flomoxef
(UHRBTBZOWWGKMK-DOMZBBRYSA-N)
Structure
SMILES
OCCn1nnnc1SCC1=C(C(=O)O)N2[C@H](OC1)[C@](C2=O)(OC)NC(=O)CSC(F)F
Type(s)
Investigational
ATC code(s)
J01DC14
Molecular Formula:
C15H18F2N6O7S2
Molecular Weight:
496.466
Log P:
-0.9618
Hydrogen Bond Acceptor:
15
Hydrogen Bond Donor:
3
TPSA:
219.6
CAS Number(s):
99665-00-6
Synonym(s)
1.
flomoxef
2.
S 6315
3.
oxacephem 6315-S
External Link(s)
MeSHC045693
PubChem Compound65864
ChEBI135813
CHEMBLCHEMBL15413
DrugBankDB11935
DrugCentral1179
KEGGdr:D07963
ZINC3874302
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Adrenocortical insufficiency chronicOFFSIDES
2Alanine Aminotransferase IncreasedOFFSIDES
3Aortic InjuryOFFSIDES
4ApneaOFFSIDES
5Aspartate aminotransferase decreasedOFFSIDES
6Aspiration PneumoniaOFFSIDES
7Base excess increasedOFFSIDES
8Bilirubin conjugated increasedOFFSIDES
9Blood alkaline phosphatase increasedOFFSIDES
10Blood beta-D-glucan increasedOFFSIDES
11Blood chloride decreasedOFFSIDES
12Blood immunoglobulin A decreasedOFFSIDES
13Blood immunoglobulin G decreasedOFFSIDES
14Blood immunoglobulin M decreasedOFFSIDES
15Blood lactate dehydrogenase increasedOFFSIDES
16Blood potassium decreasedOFFSIDES
17Blood urea increasedOFFSIDES
18CalcinosisOFFSIDES
19CholangiolitisOFFSIDES
20Clostridium colitisOFFSIDES
21Conjunctival depositOFFSIDES
22CyanosisOFFSIDES
23Cystitis viralOFFSIDES
24Cytomegalovirus antibody positiveOFFSIDES
25Depressed Level of ConsciousnessOFFSIDES
26Device related infectionOFFSIDES
27DiabetesOFFSIDES
28Discitis8786835CTD
29Disease ProgressionOFFSIDES
30Disseminated Intravascular CoagulationOFFSIDES
31Eosinophilic PneumoniaOFFSIDES
32Eosinophilic myocarditisOFFSIDES
33EpidermolysisOFFSIDES
34Epidural Abscess8786835CTD
35Erythema MultiformeOFFSIDES
36ExcoriationOFFSIDES
37Fungus serology test positiveOFFSIDES
38Gamma-Glutamyltransferase IncreasedOFFSIDES
39Gastrointestinal mucosal disorderOFFSIDES
40General nutrition disorderOFFSIDES
41Gestational DiabetesOFFSIDES
42HemiplegiaOFFSIDES
43Hepatitis BOFFSIDES
44HyperpigmentationOFFSIDES
45HyperventilationOFFSIDES
46Incisional herniaOFFSIDES
47IndurationOFFSIDES
48InfectionOFFSIDES
49Intestinal ObstructionOFFSIDES
50LaparotomyOFFSIDES
51Large intestine perforationOFFSIDES
52Leukopenia neonatalOFFSIDES
53Lymphocyte count decreasedOFFSIDES
54Meconium peritonitisOFFSIDES
55Mouth BreathingOFFSIDES
56Nephrotic SyndromeOFFSIDES
57Oculomucocutaneous syndromeOFFSIDES
58OliguriaOFFSIDES
59Oxygen saturation immeasurableOFFSIDES
60Post procedural complicationOFFSIDES
61Post procedural swellingOFFSIDES
62Postoperative feverOFFSIDES
63Postoperative wound complicationOFFSIDES
64Pulmonary InfarctionOFFSIDES
65Pulmonary thrombosisOFFSIDES
66Pyoderma GangrenosumOFFSIDES
67Renal tubular necrosisOFFSIDES
68Respiratory FailureOFFSIDES
69RhinorrheaOFFSIDES
70Skin lesionOFFSIDES
71Staphylococcal Infections8786835CTD
72Stevens-Johnson SyndromeOFFSIDES
73Vena cava filter insertionOFFSIDES
74Vitamin K DeficiencyOFFSIDES
75Wound ComplicationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.